Efficacy and safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in ovarian cancer: a systematic review of current evidence.

Fiche publication

Date publication

juin 2024

Journal

Archives of gynecology and obstetrics

Auteurs

Membres identifiés du Cancéropôle Est :
Pr AKLADIOS Chérif

Tous les auteurs :
Pavone M, Jochum F, Lecointre L, Bizzarri N, Taliento C, Restaino S, Vizzielli G, Fagotti A, Scambia G, Querleu D, Akladios C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/38879697

Résumé

PIPAC is a recent approach for intraperitoneal chemotherapy with promising results for patients with peritoneal carcinomatosis. A systematic review was conducted to assess current evidence on the efficacy and outcomes of PIPAC in patients affected by ovarian cancer.